This is indeed observed in leukocortical MS lesions, where ECM protein hyaluronan, an inhibitor of OPC differentiation [92], and its receptor CD44, are significantly increased in the WM, but not in the GM part of leukocortical lesions [41]. Here, CD44 is linked to myeloid sarcoma.